The first half of 2020 looks set to end on an encouraging note for new drug approvals despite the ongoing coronavirus pandemic. Let's take a look at the biotech stocks facing FDA decision in July.
from RTT - Biotech https://ift.tt/388FGVR
via IFTTT
No comments:
Post a Comment